CLINICAL_TRIALS
research
· 2018-03-20
Clinical Trial Update: Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer [Phase 2]
Summary
This is an update on a Phase II clinical trial evaluating neoadjuvant therapy plus minimally invasive surgery for esophageal and gastroesophageal junction cance…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Esophageal Cancer, Induction Chemotherapy | Phase 2 | Status: UNKNOWN